ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[한겨레] 국산 1호 CAR-T 치료제, 상업화 급물살…‘K-바이오 육성’ 시금석 [건강한겨레]
2026/09/17
국산 1호 CAR-T 치료제, 상업화 급물살…‘K-바이오 육성’ 시금석 [건강한겨레]
Prev
[청년의사] 넥스트 ‘림카토’ 그리는 큐로셀…루푸스부터 고형암까지 ‘완치’ 도전
Next
큐로셀 임상제조소에 튀르키예 보건부 장관 방문
ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
BUSINESS
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.
